brain cancer

Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Background: Medulloblastoma (MB) is the most common malignant paediatric brain tumour and a leading cause of cancer-related mortality …
Laura Genovesi, Amanda Millar, Elissa Tolson, Matthew Singleton, Emily Hassall, Marija Kojic, Caterina Brighi, Emily Girard, Clara Andradas, Mani Kuchibhotla, Dharmesh D Bhuva, Raelene Endersby, Nicholas G Gottardo, Anne Bernard, Christelle Adolphe, James M Olson, Melissa J Davis, Brandon J Wainwright
PDF Cite DOI
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma